Compare Cheniere Energy (LNG) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cheniere Energy vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Cheniere Energy trades at $278.18 (market cap $57.39B), while Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B). The key difference: Cheniere Energy is far larger — about 33× Nuvation Bio Inc. Class A Common Stock's market cap, and Cheniere Energy pays a 0.8% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cheniere Energy for 10 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| LNG | NUVB | |
|---|---|---|
Market Cap | $57.39B | $1.74B |
Volume | 1,215,835 | 9,289,619 |
Sector | Energy | Health |
52-Week High | $296.91 | $9.54 |
52-Week Low | $188.83 | $3.41 |
Typical Hold Time | 10 Days | 1 Days |
Enterprise Value | $82.85B | $1.33B |
Dividend Yield | 0.8% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Cheniere Energy
Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
